REG - HeiQ PLC - Temporary Suspension

HeiqAnnouncement

27/04/2023 16:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230427:nRSa7552Xa&default-theme=true

RNS Number : 7552X  HeiQ PLC  27 April 2023

27 April 2023

HeiQ Plc

("HeiQ" or "the Company")

Temporary Suspension

The Board of HeiQ Plc (LSE: HEIQ), a leading company in materials innovation
and hygiene technologies, announces that the Company will not publish its
audited financial results for the year ended 31 December 2022 by 30 April 2023
("FY 2022 Accounts"), as required by the FCA's Disclosure Guidance and
Transparency Rule 4.1.3.

 

The Company has been delayed in the preparation of its annual results
principally as a result of the acquisition and implementation of new systems
as well as changes to processes within the organisation. This has impacted the
timing of the audit work, in this first year for the Company's new auditor,
Deloitte.

 

The Company has therefore applied to the Financial Conduct Authority ("FCA")
for the listing on the Official List of the FCA of its ordinary shares of 30p
each to be temporarily suspended with effect from 7:30 a.m. on 2 May 2023. The
suspension from trading will be lifted once the 2022 Accounts have been
published. The Directors anticipate that the Company will be in a position to
publish the audited report and accounts in the coming weeks. The Company will
provide further market updates around the expected timing of the annual
results once its financial reporting and the audit work is sufficiently
progressed.

 

The information contained within this announcement is deemed to constitute
inside information as stipulated under Article 7 of EU Regulation 596/2014
(which forms part of domestic UK law pursuant to the European Union
(Withdrawal) Act 2018). Upon the publication of this announcement, this inside
information is now considered to be in the public domain.

 

For further information, please contact:

 HeiQ Plc                           +41 56 250 68 50

 Carlo Centonze (CEO)
 Cenkos Securities plc (Broker)     +44 (0) 207 397 8900

 Stephen Keys / Callum Davidson
 SEC Newgate (Media Enquiries)      +44 (0) 20 3757 6882

 Elisabeth Cowell / Molly Gretton   heiq@secnewgate.co.uk (mailto:heiq@secnewgate.co.uk)

 

About HeiQ

HeiQ is focused on improving the lives of billions of people world-wide by
innovating the materials people use every day. HeiQ has strong IP which is at
the forefront of global technology in the $10 billion antimicrobial fabrics
market, $24 billion textile chemicals market, the $50 billion probiotics
market and the $150 billion man-made fibers market. It has also moved into the
medical device, healthcare and hygiene coatings markets, to help make
hospitals and healthcare environments more hygienic. HeiQ aims to deliver
growth for its shareholders through a combination of increased sales of its
core products and by entering additional lucrative markets through disruptive
innovations and M&A.

 

HeiQ has created some of the most effective, durable and high-performance
technologies in the market today, which cool, warm, dry, repel, purify, and
destroy viruses. Since 2005, HeiQ has developed over 200 technologies in
partnership with 300 major brands and it has a significant R&D pipeline
containing over 50 projects. The Company has won multiple awards and gained a
strong reputation for the ESG & sustainable downstream effect of its
innovations. HeiQ is the only company to have won the Swiss Technology award
twice. It has also won the Swiss Environmental award with an innovation that
saves energy and water consumption during the textile manufacturing process.

 

Led by an experienced leadership team, HeiQ researches new solutions for
partners, delivers scaled up manufacturing from its sites across the world and
helps partners market the product to end consumers - aiming for lab to
consumer in months.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  SUSPPUGCCUPWGCM